Stallion India Fluorochemicals Limited (NSE:STALLION)
India · Delayed Price · Currency is INR 228.25
+1.40 (0.62%)
Aug 21, 2026, 3:29 PM IST
NSE:STALLION Revenue
Stallion India Fluorochemicals had revenue of 1.21B INR in the quarter ending June 30, 2026, with 9.93% growth. This brings the company's revenue in the last twelve months to 4.42B, up 6.48% year-over-year. In the fiscal year ending March 31, 2026, Stallion India Fluorochemicals had annual revenue of 4.31B with 14.10% growth.
Revenue (ttm)
4.42B
Revenue Growth
+6.48%
P/S Ratio
6.00
Revenue / Employee
220.83M
Employees
20
Market Cap
26.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.31B | 532.28M | 14.10% |
| Mar 31, 2025 | 3.77B | 1.44B | 61.83% |
| Mar 31, 2024 | 2.33B | 76.55M | 3.39% |
| Mar 31, 2023 | 2.26B | 392.57M | 21.07% |
| Mar 31, 2022 | 1.86B | 683.50M | 57.94% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 48.53B |
| Laxmi Organic Industries | 31.22B |
| Rossari Biotech | 25.50B |
| S H Kelkar and Company | 24.49B |
| Veedol Corporation | 22.63B |
| Jubilant Agri and Consumer Products | 19.72B |
| NOCIL | 13.70B |
| Advanced Enzyme Technologies | 7.50B |